Patients with bacterial vaginosis (BV) or vulvovaginal candidiasis (VVC)
Conditions
Interventions
Bacterial Vaginosis:Control Group:Metronidazole: Oral, 400mg twice daily, Days 1-7.
Bacterial Vaginosis:Experimental Group:Lactobacillus Vaginal Capsules: Intravaginal administration, 2 capsules once nightly, Days 1-21.
Metronidazole: Oral, 400mg twice daily, Days 1-7.
Vulvovaginal Candidiasis: Control Group:Fluconazole: Oral, 150mg once daily, Days 1 and 4.
Vulvovaginal Candidiasis:Experimental Group:Lactobacillus Vaginal Capsules: Intravaginal administration, 2 capsules once nightly, Days 1-21.
Fluconazole: Oral, 150mg once daily, Days 1 and 4.
Sponsors
Obstetrics and Gynecology Hospital Affiliated to Fudan University
Eligibility
Sex/Gender
Female
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18-75 years (inclusive); 2. Clinical symptoms and pathogenetic tests meet the diagnostic criteria for bacterial vaginosis (BV) or vulvovaginal candidiasis (VVC); 3. Agree to participate in this clinical study and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Pregnant or breastfeeding women or patients who plan to have children within 3 months; 2. Hypersensitivity to the test drug (including microecological agents); 3. Those who have a combination of other infectious diseases of the genitourinary system (e.g. acute urethritis, acute cystitis, trichomoniasis vaginalis, aerobic vaginitis, etc.); 4. Persons with mental illnesses, psychological disorders that cannot be properly expressed; 5. any other condition that, in the opinion of the investigator, makes participation in this clinical study inappropriate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Microscopic examination of vaginal discharge; | — |
Secondary
| Measure | Time frame |
|---|---|
| Complete Blood Count;Urine routine;Liver Function Tests - LFTs; | — |
Countries
China
Contacts
Public ContactSui Long
Obstetrics and Gynecology Hospital Affiliated to Fudan University
Outcome results
None listed